Dr. Leung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Route 206 and Province Line Road,
Princeton, NJ 08543Phone+1 609-252-3269
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Nuclear Radiology, 2008 - 2009
- New York Presbyterian Hospital (Columbia Campus)Residency, Radiology-Diagnostic, 2004 - 2008
- Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2003 - 2004
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2003
Certifications & Licensure
- NY State Medical License Active through 2024
- NJ State Medical License 2012 - 2017
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- Philip Johnson Fellowship in Nuclear Medicine Columbia University, 2008-2009
- Ross Golden Research Resident Award in Radiology Columbia University Department of Radiology, 2008
- magna cum laude Columbia College, Columbia University, 1994
- Join now to see all
Clinical Trials
- Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 218 citationsPhase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.Michael Lim, Michael Weller, Ahmed Idbaih, Joachim Steinbach, Gaetano Finocchiaro
Neuro-Oncology. 2022-11-02 - 27 citationsSafety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.Hamid Emamekhoo, Mark R. Olsen, Bradley Curtis Carthon, Alexandra Drakaki, Ivor John Percent
Cancer. 2021-11-16 - 38 citationsFirst-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial.Laurence Albiges, Nizar M. Tannir, Mauricio Burotto, David F. McDermott, Elizabeth R. Plimack
European Urology. 2021-11-05
Journal Articles
- Neoadjuvant GTX Followed by GX/RT and Surgery in Locally Advanced, Unresectable Pancreatic AdenocarcinomaSherman, W.H., Chu, K., Chabot, J., Allendorf, J., Schrope, B.A., Hecht, E., Jin, B., Leung, D., Remotti, H., Addeo, G., Postolov, I., Wei, T., Fine, R.L., Cancer
- Behind the Name: Eponyms of NeuroradiologyChow, D.S., Essa, S.S., Kozberg, M.K., Lanzman, B., Miloushev, V.Z., Leung, D.K., Utukuri P.S., Filippi, C.G., and Lignelli, A., Neurographics
- Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinomaEinersen, P., Epelboym,I., Winner, M.D., Leung, D., Chabot, J.A., Allendorf, J.D., Journal of Gastrointestinal Surgery, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Can Pretreatment PET-CT Predict RECIST 1.1 Response in Subjects with Locally Advanced Pancreatic Adenocarcinoma Undergoing Neoadjuvant GTX Chemotherapy?Jin, B., Hecht, E.M., Leung, D.K., Chu, K., Sandhu, R.S., Sherman, W.H., RSNA, 2014
- Retrospective analysis of cancer cachexia in patients with lung cancerHuang, K., Malhotra, S., Villanueva, N., Beck, K., Dietz, D., Consul, N., Fenn, K., Coke, C., Biswa, A., Divgi, C., Leung, D., Halmos, B., Vinnakota, R., Gavrancic, T...., Cancer Cachexia Conference, 2014
- Utility of MIBI SPECT-CT and contrast-enhanced CT in primary hyperparathyroidismLeung, D.K., Eckstein, D.A., Lameka, K.A., Lee, J.A., Divgi, C.R., Society of Nuclear Medicine, 2014
- Join now to see all
Professional Memberships
- Member
- Member
External Links
- Columbiahttp://columbia.edu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: